MENU

Articles for Dechra Pharmaceuticals (LSE: DPH)

This FTSE 250 dog might be a stonking contrarian pick

Today's trading update suggests investors are being far too negative on this FTSE 250 (INDEXFTSE:MCX) stock. More »

2 surprising growth stocks that could help you retire early

These two shares may offer higher growth rates than expected. More »

These great growth stocks have much further to go

Royston Wild looks at two stocks with hot earnings prospects. More »

One growth stock I’d buy — and one I’d sell — right now

Royston Wild discusses two growth stocks with very different near-term outlooks. More »

Enjoy double-digit earnings growth with these FTSE 250 stars

Royston Wild looks at three FTSE 250 (INDEXFTSE: MCX) stocks with spectacular earnings potential. More »

Why I’m avoiding these exciting growth shares right now

Bilaal Mohamed explains why investors should wait before buying these growth stocks. More »

Should you make room for Pets At Home Group plc after today’s update?

The market may not like today's update but Paul Summers thinks Pets At Home Group plc (LON:PETS) is a sound defensive play. More »

Does this pharma’s 56% sales growth make it a better buy than GlaxoSmithKline plc?

Should you sell GlaxoSmithKline plc (LON: GSK) and pile into this hot pharma stock? More »

4 growth stocks to put on your 2017 shopping list

Royston Wild runs the rule over some of London’s hottest growth stocks. More »

Could these top-performing stocks be about to collapse?

Bilaal Mohamed considers whether these shares are heading for a correction after this year's spectacular gains. More »

2 shining pharmaceuticals stars to challenge the big guns?

Can these smaller upstarts beat the champions at their own game? More »

Is Dechra Pharmaceuticals plc a better buy than GlaxoSmithKline plc after today’s news?

Royston Wild weighs up the investment potential of drugs deities Dechra Pharmaceuticals plc (LON: DPH) and GlaxoSmithKline plc (LON: GSK). More »

4 perfect stocks for ‘Brexit Britain’!

Royston Wild reveals a cluster of stocks waiting to deliver plump shareholder returns. More »

Are RhythmOne plc, Dechra Pharmaceuticals plc and Pagegroup plc ‘buys’ after today’s updates?

Should you pile-in to these three stocks right now? RhythmOne plc (LON: RTHM), Dechra Pharmaceuticals plc (LON: DPH) and Pagegroup plc (LON: PAGE). More »

Should you be buying AstraZeneca plc, Alliance Pharma plc and Dechra Pharmaceuticals plc today?

Are these three healthcare stocks ripe for investment? AstraZeneca plc (LON: AZN), Alliance Pharma plc (LON: APH) and Dechra Pharmaceuticals plc (LON: DPH). More »

Should You Buy Dechra Pharmaceuticals plc, Enquest Plc & Cairn Energy PLC Today?

Royston Wild runs the rule over headline makers Dechra Pharmaceuticals plc (LON: DPH), Enquest Plc (LON: ENQ) and Cairn Energy PLC (LON: CNE). More »

Are GlaxoSmithKline plc, Dechra Pharmaceuticals plc & CareTech Holdings plc On The Cusp Of Stunning Returns?

Could these 3 healthcare stocks transform your portfolio? GlaxoSmithKline plc (LON: GSK), Dechra Pharmaceuticals plc (LON: DPH) and CareTech Holdings plc (LON: CTH) More »

4 Great Growth Picks For 2016 And Beyond: Barclays PLC, Dechra Pharmaceuticals plc, Britvic Plc And Marks & Spencer Group Plc

Royston Wild analyses the growth potential of Barclays PLC (LON: BARC), Dechra Pharmaceuticals plc (LON: DPH), Britvic Plc (LON: BVIC) and Marks & Spencer... More »

Are AstraZeneca plc, Indivior PLC & Dechra Pharmaceuticals plc Set To Double by 2016?

AstraZeneca plc (LON:AZN), Indivior PLC (LON:INDV) and Dechra Pharmaceuticals plc (LON:DPH) offer three very different risk profiles, argues Alessandro Pasetti. More »

Why AstraZeneca plc, Dechra Pharmaceuticals plc And Tissue Regenix Group PLC Are A Perfect Healthcare Combination

AstraZeneca plc (LON:AZN), Dechra Pharmaceuticals plc (LON:DPH) and Tissue Regenix Group PLC (LON:TRX) are a terrific trio to buy today. More »